Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-23

Clinical Trial Update: Meclizine Plasma Levels in Responders and Non-responders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining meclizine plasma levels in responders and non-responders for seasickness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meclizine (meclizine)

Snippet

Sponsor: Medical Corps, Israel Defense Force | Conditions: Seasickness, Meclizine | Phase 4 | Status: UNKNOWN